losartan has been researched along with Fong Disease in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with enalapril for 2 years (0." | 1.35 | Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment. ( Devriendt, K; Proesmans, W; Van Dyck, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Proesmans, W | 1 |
Van Dyck, M | 1 |
Devriendt, K | 1 |
1 other study available for losartan and Fong Disease
Article | Year |
---|---|
Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Com | 2009 |